본문 바로가기
KERD
논문KCI 등재

RNA Regulation in Neurologic Disease and Cancer

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류의학일반

초록

The paraneoplastic neurologic diseases (PNDs) are brain degenerations that develop in the setting of clinically inapparent cancers. PNDs arise when common cancers express brain proteins, triggering an anti-tumor immune response and tumor immunity. Research on these brain-cancer proteins has revealed a new world of neuron-specific RNA binding proteins whose functions may be aberrantly used by tumor cells. Efforts to gain insight into their function has led to the development of new methods and strategies to understand RNA protein regulation in living tissues.

Abstract

The paraneoplastic neurologic diseases (PNDs) are brain degenerations that develop in the setting of clinically inapparent cancers. PNDs arise when common cancers express brain proteins, triggering an anti-tumor immune response and tumor immunity. Research on these brain-cancer proteins has revealed a new world of neuron-specific RNA binding proteins whose functions may be aberrantly used by tumor cells. Efforts to gain insight into their function has led to the development of new methods and strategies to understand RNA protein regulation in living tissues.

참고문헌 (44)

  1. Darnell RB, "Characterization of antigens bound by CSF and serum of a patient with cerebellar degeneration: coexpression in Purkinje cells and tumor lines of neuroectodermal origin", Neurology, 39, pp.385~ (1989)
  2. Darnell RB, "Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons, and neuroectodermal tumors", J Neurosci, 11, pp.1224~1130 (1991)
  3. "Soc Neurosci", 1992, 1092~
  4. Newman LS, "Beta-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein", Cell, 82, pp.773~783 (1995)
  5. Darnell RB, "Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain", Proc Natl Acad Sci U S A, 93, pp.4529~4536 (1996)
  6. Musunuru K, "Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration", Annu Rev Neurosci, 24, pp.239~262 (2001)
  7. Dredge BK, "The splice of life: alternative splicing and neurological disease", Nat Rev Neurosci, 2, pp.43~50 (2001)
  8. Licatalosi DD, "Splicing regulation in neurologic disease", Neuron, 52, pp.93~101 (2006)
  9. Albert ML, "Paraneoplastic neurological degenerations: keys to tumour immunity", Nat Rev Cancer, 4, pp.36~44 (2004)
  10. Roberts WK, "Neuroimmunology of the paraneoplastic neurological degenerations", Curr Opin Immunol, 16, pp.616~622 (2004)
  11. Darnell RB, "Paraneoplastic syndromes affecting the nervous system", Semin Oncol, 33, pp.270~298 (2006)
  12. Albert ML, "Tumorspecific killer cells in paraneoplastic cerebellar degeneration", Nat Med, 4, pp.1321~1324 (1998)
  13. Albert ML, "Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration", Ann Neurol, 47, pp.9~17 (2000)
  14. Frank MO, "Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer", PLoS One 2010 in press, ~
  15. Santomasso BD, "A T-cell receptor associated with naturally occurring human tumor immunity", Proc Natl Acad Sci U S A, 104, pp.19073~19078 (2007)
  16. Buckanovich RJ, "Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system", Neuron, 11, pp.657~672 (1993)
  17. Yang YY, "The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia", Proc Natl Acad Sci U S A, 95, pp.13254~13259 (1998)
  18. Graus F, "Neuronal antinuclear antibody in sensory neuronopathy from lung cancer", Neurology, 35, pp.538~543 (1985)
  19. Szabo A, "HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal", Cell, 67, pp.325~333 (1991)
  20. Hinman MN, "Diverse molecular functions of Hu proteins", Cell Mol Life Sci, 65, pp.3168~3181 (2008)
  21. Buckanovich RJ, "The onconeural antigen Nova-1 is a neuronspecific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies", J Neurosci, 16, pp.1114~1122 (1996)
  22. Green R, "In vitro genetic analysis: selection and amplification of rare functional nucleic acids", Methods Compan Methods Enzymol, 2, pp.75~86 (1991)
  23. Szostak JW, "In vitro selection of functional RNA sequences. In: The RNA world", pp.511~533 (1993), Cold Spring Harbor Laboratory Press
  24. Buckanovich RJ, "The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo", Mol Cell Biol, 17, pp.3194~3201 (1997)
  25. Jensen KB, "The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain", Proc Natl Acad Sci U S A, 94, pp.5740~5745 (2000)
  26. Lewis HA, "Sequencespecific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome", Cell, 100, pp.323~332 (2000)
  27. Dredge BK, "Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer", Mol Cell Biol, 23, pp.4687~4700 (2003)
  28. Dredge BK, "Nova autoregulation reveals dual functions in neuronal splicing", EMBO J, 24, pp.1608~1620 (2005)
  29. Darnell RB, "Developing global insight into RNA regulation", Cold Spring Harb Symp Quant Biol, 71, pp.321~327 (2006)
  30. Ule J, "Nova regulates brainspecific splicing to shape the synapse", Nat Genet, 37, pp.844~852 (2005)
  31. Ule J, "An RNA map predicting Nova-dependent splicing regulation", Nature, 444, pp.580~586 (2006)
  32. Ule J, "CLIP identifies Novaregulated RNA networks in the brain", Science, 302, pp.1212~1215 (2003)
  33. Darnell RB, "HITS-CLIP: panoramic views of protein-RNA regulation in living cells", Wiley Interdiscip Rev, 1, pp.266~286 (2010)
  34. Licatalosi DD, "HITS-CLIP yields genome-wide insights into brain alternative RNA processing", Nature, 456, pp.464~469 (2008)
  35. Licatalosi DD, "RNA processing and its regulation: global insights into biological networks", Nat Rev Genet, 11, pp.75~87 (2010)
  36. Zhang C, "Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls", Science, 329, pp.439~443 (2010)
  37. Hafner M, "Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP", Cell, 141, pp.129~141 (2010)
  38. König J, "iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution", Nat Struct Mol Biol, 17, pp.909~915 (2010)
  39. Sanford JR, "Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts", Genome Res, 19, pp.381~394 (2009)
  40. Yeo GW, "An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells", Nat Struct Mol Biol, 16, pp.130~137 (2009)
  41. Xue Y, "Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping", Mol Cell, 36, pp.996~1006 (2009)
  42. Chi SW, "Argonaute HITS-CLIP decodes microRNAmRNA interaction maps", Nature, 460, pp.479~486 (2009)
  43. Zisoulis DG, "Comprehensive discovery of endogenous Argonaute binding sites in Caenorhabditis elegans", Nat Struct Mol Biol, 17, pp.173~179 (2010)
  44. Xu M, "MIWI-independent small RNAs (MSY-RNAs) bind to the RNA-binding protein, MSY2, in male germ cells", Proc Natl Acad Sci U S A, 106, pp.12371~12376 (2009)

관련 논문AI추천

이 간행물의 다른 논문 (9건)